Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
2015 · Journal of Clinical Oncology · 959 citations
https://doi.org/10.1200/jco.2014.58.0225
M
Meenakshi Hegde
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
5.8K
Citations
25
h-index
38
i10-index
Meenakshi Hegde is an academic researcher from Houston Methodist. The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 25, co-authored 137 publications.
ORCID: 0000-0002-7778-7871Papers by this author
worksTandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
2016 · Journal of Clinical Investigation · 662 citations
https://doi.org/10.1172/jci83416
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
2013 · Molecular Therapy — Nucleic Acids · 450 citations
https://doi.org/10.1038/mtna.2013.32
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
2017 · Neuro-Oncology · 409 citations
https://doi.org/10.1093/neuonc/nox182
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
2020 · Leukemia · 181 citations
https://doi.org/10.1038/s41375-020-0792-2
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
2020 · Nature Communications · 161 citations
https://doi.org/10.1038/s41467-020-17175-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat